Biolevox™ HA 2.2%

  • Biolevox™ HA 2.2% 1
  • Biolevox™ HA 2.2% 2
  • Biolevox™ HA 2.2% 3
Product Description

Biolevox™ HA 2.2% is a hyaluronic acid (HA) gel designed for a three intra-articular injection into the osteoarthritis (OA) affected in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint. Designed HA-based gel contains 44 mg of hyaluronate in 2 ml pre-filled syringe. The combination of high concentration of hyaluronate and optimally high molecular weight creates gel characterized with optimally high viscosity and elasticity. With those properties Biolevox™ HA 2.2% is an ideal solution for a triple intra-articular injection viscosupplementation therapy.

Read more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Bone & Joint Health; Brand Name
  • Model
    Biolevox™
  • Supplied from
    Poland
  • Measured In
    piece
More specifications Fewer specifications
Sales Markets
Show more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
View company profile

More Products from Biovico Sp. z o.o. (2)

  • Lipotris

    Product Lipotris

    Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris(TM) therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage sur...
  • Wint™ kit

    Product Wint™ kit

    Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...

Biovico Sp. z o.o. resources (2)